University of Genoa   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Genoa Italy (1481)

Organization Overview

First Clinical Trial
1996
NCT02450058
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

3) Clinica di Malattie dell'Apparato Respiratorio e Allergologia, Dipartimento di Medicina Interna, University of Genoa, Italy | Allergy and Respiratory Diseases University of Genoa | Azienda Ospedaliera Universitaria San Martino Genoa, Italy | Benno Rehberg-Klug | Centro della Microcitemia e delle Anemie Congenite E.O. Ospedali Galliera- Genova Italy | Centro Dipartimentale di Fisiopatologia Respiratoria, University of Genoa, Italy (Co-ordinating centre) | Department of Health Sciences, University of Genoa | Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, Italy | Dipartimento di Neuroscienze DINOG, Universita degli Studi di Genova, Italy | Division of Medical Oncology, E.O. Galliera, Genoa, Italy | Dr. Luca Boni U.O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino - IST NORD CBA | Ente Ospedaliero Ospedali Galliera | E.O. Galliera, Genoa, Italy | E.O. Ospedali Galliera | E.O.Ospedali Galliera | E.O. Ospedali Galliera. Centro della Microcitemia e delle Anemie Congenite -Ematology - Genoa Italy | E.O. Ospedali Galliera Genova | Gaslini Children's Hospital | G. Gaslini Hospital | Hematology Division, IRCCS AOU San Martino, Genova, Italy | HUG | IRCCS AOU San Martino, Genova, Italy | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | IRCCS Gaslini, Genoa. | IRCCS Giannina Gaslini, Genova, Italy | Istituto G. Gaslini | Istituto Giannina Gaslini | Istituto Giannina Gaslini-PRINTO | Istituto Giannina Gaslini_PRINTO Chairman | Istituto Giannina Gaslini _ PRINTO Senior Scientist | Lucia Del Mastro,MD | Ospedale Policlinico San Martino | Ospedale Policlinico San Martino di Genova | Ospedale Policlinico San Martino-IST | Ospedale S.Martino e Cliniche Universitarie Convenzionate, Genova, Italy | Ospedale S.Martino, Genova | Ospedale S.Martino - Genova (Italy) | Ospedali Galliera, Genova | Pediatric Gastroenterology Unit, IRCCS Gaslini, Genoa. | Prof. Olivier Bugnon | San Martino University Hospital | S.C. Geriatria E.O. Ospedali Galliera - Genova Italy | Unit of Preventive and Occupational Medicine, University Hospital San Martino, Genoa, Italy | Universita degli Studi di Genova | University Hospital San Martino, Genoa, Italy | University of Geneva | University of Genoa | University of Genova | University of Genova Endocrinology Unit | University of Medicine, Genoa, Italy | UOC Nefrologia, Dialisi e Trapianto, IRCCS Giannina Gaslini, Genova, Italy | U.O. Nefrologia e Dialisi; Istituto di Ricovero e Cura a Carattere Scientifico Giannina Gaslini | Vito Brusasco Centro Dipartimentale di Fisiopatologia Respiratoria, University of Genoa, Italy (Co-ordinating centre)

Active Ingredients

Drugs in Phase 4 Trials (24)

acetaminophen (tylenol) (1 trial)

albuterol (proventil) (3 trials)

birch allergen (1 trial)

dexmedetomidine (precedex) (2 trials)

dimethyl fumarate (tecfidera) (1 trial)

fingolimod (gilenya) (1 trial)

fosfomycin (monurol) (1 trial)

hyaluronic acid (1 trial)

hypromelloses (1 trial)

lanreotide (somatuline depot) (1 trial)

levobupivacaine (chirocaine) (3 trials)

metronidazole (flagyl) (1 trial)

morphine (2 trials)

nitrofurantoin (furadantin) (2 trials)

ozonated oil (1 trial)

prednisone (meticorten) (4 trials)

procaine benzylpenicillin (novocaine) (2 trials)

remifentanil (ultiva) (2 trials)

ropivacaine (naropin) (1 trial)

sufentanil (2 trials)

tiotropium (spiriva) (2 trials)

tranexamic acid (cyklokapron) (1 trial)

vedolizumab (entyvio) (1 trial)

virosomal influenza vaccine (1 trial)

Drugs in Phase 3 Trials (50)

abacavir (ziagen) (1 trial)

anakinra (Kineret) (1 trial)

anastrozole (arimidex) (1 trial)

azathioprine (imuran) (1 trial)

beclomethasone (vanceril) (2 trials)

bictegravir (Biktarvy) (1 trial)

cannabis (1 trial)

carboplatin (paraplatin) (4 trials)

cefixime (suprax) (1 trial)

cinacalcet (sensipar) (1 trial)

cisplatin (platinol) (2 trials)

clavulanate (Augmentin) (1 trial)

clofarabine (clolar) (1 trial)

cyclophosphamide (cytoxan) (9 trials)

cyclosporine (sandimmune) (2 trials)

dapagliflozin (farxiga) (1 trial)

Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine (Kinrix) (1 trial)

docetaxel (taxotere) (2 trials)

dolutegravir (tivicay) (2 trials)

doxorubicin (Doxil) (2 trials)

emtricitabine (emtriva) (1 trial)

epirubicin (ellence) (4 trials)

etanercept (enbrel) (1 trial)

etoposide (vepesid) (3 trials)

exemestane (aromasin) (2 trials)

Filgrastim (neupogen) (1 trial)

fluorouracil (efudex) (5 trials)

follitropin alfa (Gonal-F) (1 trial)

ganirelix (1 trial)

iron (1 trial)

ketotifen (zaditor) (1 trial)

lactobacillus rhamnosus (1 trial)

lamivudine (epivir) (2 trials)

letrozole (femara) (3 trials)

menopausal gonadotropin (1 trial)

methotrexate (1 trial)

methylprednisolone (medrol) (2 trials)

naltrexone (revia) (2 trials)

octreotide (sandostatin) (1 trial)

paclitaxel (taxol) (7 trials)

pertagen (1 trial)

pregabalin (lyrica) (1 trial)

rituximab (rituxan) (6 trials)

safinamide (xadago) (1 trial)

tamoxifen (nolvadex) (2 trials)

tenofovir alafenamide (genvoya) (1 trial)

thalidomide (Thalomid) (1 trial)

triamcinolone (kenalog) (1 trial)

trimethoprim (1 trial)

triptorelin (Trelstar) (2 trials)

Drugs in Phase 2 Trials (44)

acetylsalicylic acid (aspirin) (1 trial)

aldesleukin (Proleukin) (2 trials)

atezolizumab (Tecentriq) (1 trial)

autologous mesenchymal stem cells (1 trial)

azacitidine (vidaza) (1 trial)

bevacizumab (avastin) (2 trials)

brentuximab vedotin (adcetris) (1 trial)

capecitabine (xeloda) (1 trial)

caspofungin (cancidas) (1 trial)

chlorhexidine (hibitane) (1 trial)

cobimetinib (cotellic) (1 trial)

daratumumab (darzalex) (1 trial)

deferiprone (ferriprox) (1 trial)

dinutuximab (unituxin) (2 trials)

dobesilic acid (1 trial)

durvalumab (imfinzi) (1 trial)

evolocumab (repatha) (1 trial)

formoterol (foradil) (1 trial)

fotemustine (1 trial)

gefitinib (iressa) (2 trials)

gemcitabine (gemzar) (1 trial)

gx301 (1 trial)

isotretinoin (Accutane) (1 trial)

mannitol (Osmitrol) (1 trial)

mesna (mesnex) (1 trial)

mycophenolate (CellCept) (2 trials)

neridronic acid (1 trial)

ngr-htnf (1 trial)

niraparib (zejula) (1 trial)

nivolumab (opdivo) (1 trial)

octreotate (1 trial)

ofatumumab (arzerra) (2 trials)

oxaliplatin (eloxatin) (1 trial)

pembrolizumab (keytruda) (1 trial)

pemetrexed (alimta) (1 trial)

regorafenib (stivarga) (1 trial)

sirolimus (rapamune) (1 trial)

sitagliptin (januvia) (1 trial)

tacrolimus (prograf) (1 trial)

trastuzumab (herceptin) (1 trial)

trifolium pratense (1 trial)

vemurafenib (zelboraf) (2 trials)

vincristine (oncovin) (1 trial)

vinorelbine (navelbine) (2 trials)

Drugs in Phase 1 Trials (4)

ino-4201 (1 trial)

irinotecan (Camptosar) (1 trial)

leucovorin (1 trial)

virus-specific T cells (1 trial)

Drugs in Other Trials (4)

gemeprost (1 trial)

nitrous oxide (1 trial)

osmotin (1 trial)

sevoflurane (ultane) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acromegaly (Phase 4)

Acute Disease (Phase 3)

Amyotrophic Lateral Sclerosis (Phase 2)

Arthritis (Phase 3)

Arthritis, Juvenile (Phase 3)

Aspergillosis (Phase 2)

Asthma (Phase 3)

beta-Thalassemia (Phase 2)

Breast Neoplasms (Phase 3)

Bronchiolitis (Phase 4)

Bronchiolitis Obliterans (Phase 4)

Carcinoma in Situ (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Carcinoma, Ovarian Epithelial (Phase 3)

Cataract (Phase 4)

Chronic Periodontitis (Phase 4)

Colitis (Phase 3)

Colitis, Ulcerative (Phase 3)

Colonic Neoplasms (Phase 2)

Colorectal Neoplasms (Phase 2)

Communicable Diseases (Phase 4)

Congenital Abnormalities (Phase 3)

Conjunctivitis (Phase 2)

Conjunctivitis, Allergic (Phase 3)

Craniosynostoses (Phase 4)

Crohn Disease (Phase 4)

Cystitis (Phase 4)

Dermatomyositis (Phase 3)

Digestive System Neoplasms (Phase 2)

Disease Progression (Phase 2)

Endocrine Gland Neoplasms (Phase 2)

Eye Infections (Phase 4)

Gastrointestinal Neoplasms (Phase 2)

Giant Cell Arteritis (Phase 4)

Glomerulonephritis (Phase 3)

Glomerulonephritis, Membranous (Phase 3)

Hodgkin Disease (Phase 2)

Hyperparathyroidism (Phase 3)

Hyperparathyroidism, Secondary (Phase 3)

Infarction (Phase 2)

Infections (Phase 4)

Infertility (Phase 3)

Inflammatory Bowel Diseases (Phase 3)

Influenza, Human (Phase 4)

Intestinal Diseases (Phase 3)

Iron Overload (Phase 2)

Keratoconjunctivitis (Phase 3)

Kidney Diseases (Phase 3)

Leukemia (Phase 3)

Lung Diseases (Phase 2)

Lung Diseases, Obstructive (Phase 2)

Lung Neoplasms (Phase 3)

Lupus Erythematosus, Systemic (Phase 3)

Lymphoma (Phase 2)

Melanoma (Phase 2)

Motor Neuron Disease (Phase 2)

Multiple Endocrine Neoplasia (Phase 2)

Multiple Sclerosis (Phase 4)

Multiple Sclerosis, Relapsing-Remitting (Phase 4)

Myelodysplastic Syndromes (Phase 2)

Myocardial Infarction (Phase 2)

Neoplasm Metastasis (Phase 3)

Neoplasms (Phase 2)

Nephritis (Phase 3)

Nephrosis (Phase 3)

Nephrosis, Lipoid (Phase 3)

Nephrotic Syndrome (Phase 3)

Nerve Degeneration (Phase 2)

Neuroblastoma (Phase 2)

Neurodegenerative Diseases (Phase 2)

Neuroendocrine Tumors (Phase 2)

Osteoporosis (Phase 2)

Ovarian Neoplasms (Phase 3)

Pain, Postoperative (Phase 4)

Pain, Procedural (Phase 3)

Pancreatic Neoplasms (Phase 2)

Pantothenate Kinase-Associated Neurodegeneration (Phase 2)

Parkinson Disease (Phase 3)

Periodontitis (Phase 4)

Polymyalgia Rheumatica (Phase 4)

Postoperative Hemorrhage (Phase 3)

Preleukemia (Phase 2)

Prostatic Neoplasms (Phase 2)

Puerperal Disorders (Phase 4)

Pulmonary Disease, Chronic Obstructive (Phase 2)

Renal Insufficiency, Chronic (Phase 3)

Respiratory Tract Neoplasms (Phase 2)

Rhinitis (Phase 4)

Rhinitis, Allergic (Phase 4)

Sclerosis (Phase 4)

ST Elevation Myocardial Infarction (Phase 2)

Syndrome (Phase 3)

Thalassemia (Phase 2)

Thymus Neoplasms (Phase 2)

Ulcer (Phase 3)

Urinary Tract Infections (Phase 4)

Vesico-Ureteral Reflux (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 94
  • # of Trial APIs: 126